Global Self-Monitoring Blood Glucose (SMBG) Devices Market Research Report 2022 - Market Size, Current Insights and Development Trends

Global Self-Monitoring Blood Glucose (SMBG) Devices Market Research Report 2022 - Market Size, Current Insights and Development Trends

The report focuses on the Self-Monitoring Blood Glucose (SMBG) Devices market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Self-Monitoring Blood Glucose (SMBG) Devices market.

Major Players in the Self-Monitoring Blood Glucose (SMBG) Devices market are:

ARKRAY, Inc.
Apex Biotechnology Corp.
Abbott Laboratories
Trividia Health, Inc. (Sinocare Inc. )
Terumo Corporation
B. Braun Melsungen AG
PHC Holdings Corporation
Beurer GmbH
F. Hoffmann-La Roche Ltd.
LifeScan IP Holdings, LLC
Ypsomed Holding AG
Bionime Corporation
Dariohealth Corp.

On the basis of types, the Self-Monitoring Blood Glucose (SMBG) Devices market is primarily split into:

Test Strips
Lancets
Blood Glucose Meters

On the basis of applications, the market covers:

Public Hospital
Private Hospital
Clinics
Pharmacy Shops

Major Regions or countries covered in this report:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029